After months of threats, President Trump eased up pressure on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing just fine. Talk of ...

Dec 30 (Reuters) - Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health regulator, becoming the first ...

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is ...

NEW YORK, Dec 31 (Reuters) - Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even ...

2024 US pharma trade deficit was $115.5B, with largest deficit of $45.5B with Ireland. Trump proposed 100% tariffs on certain pharma imports to encourage US drug manufacturing. US imports most ...

Jan 20 (Reuters) - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.

Shares of an embattled biotech called Ironwood Pharmaceuticals jumped more than 30% in the first trading hours of the new year as investors reacted to a markedly better-than-expected outlook for sales ...